JHS

JHS Svendgaard Laboratories Share Price

₹21.50 -0.21 (-0.97%)

21 Nov, 2024 14:44

SIP TrendupStart SIP in JHS

Start SIP

Performance

  • Low
  • ₹21
  • High
  • ₹23
  • 52 Week Low
  • ₹16
  • 52 Week High
  • ₹40
  • Open Price₹22
  • Previous Close₹22
  • Volume153,173

Investment Returns

  • Over 1 Month -21.25%
  • Over 3 Month -7.3%
  • Over 6 Month + 15.82%
  • Over 1 Year -16.76%
SIP Lightning

Smart Investing Starts Here Start SIP with JHS Svendgaard Laboratories for Steady Growth!

Invest Now

JHS Svendgaard Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -15.7
  • PEG Ratio
  • -0.7
  • Market Cap Cr
  • 184
  • P/B Ratio
  • 1.1
  • Average True Range
  • 1.5
  • EPS
  • 0
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.96
  • RSI
  • 29.22
  • MFI
  • 33.71

JHS Svendgaard Laboratories Financials

JHS Svendgaard Laboratories Technicals

EMA & SMA

Current Price
₹21.50
-0.21 (-0.97%)
pointer
  • stock-down_img
  • Bullish Moving Average 0
  • stock-up_img
  • Bearish Moving Average 16
  • 20 Day
  • ₹24.51
  • 50 Day
  • ₹25.67
  • 100 Day
  • ₹25.23
  • 200 Day
  • ₹24.30

Resistance and Support

22.03 Pivot Speed
  • R3 23.96
  • R2 23.42
  • R1 22.57
  • S1 21.18
  • S2 20.64
  • S3 19.79

What's your outlook on JHS Svendgaard Laboratories?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Jhs Svendgaard Labs. has an operating revenue of Rs. 80.13 Cr. on a trailing 12-month basis. An annual revenue de-growth of -32% needs improvement, Pre-tax margin of -5% needs improvement, ROE of -2% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 13 which is a POOR score indicating inconsistency in earnings, a RS Rating of 30 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 112 indicates it belongs to a poor industry group of Cosmetics/Personal Care and a Master Score of D is close to being the worst. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

JHS Svendgaard Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-13 Quarterly Results
2024-08-12 Quarterly Results
2024-06-04 Preferential issue of shares
2024-05-18 Audited Results
2024-02-14 Quarterly Results

JHS Svendgaard Laboratories F&O

JHS Svendgaard Laboratories Shareholding Pattern

34.56%
1.69%
46.53%
17.22%

About JHS Svendgaard Laboratories

  • NSE Symbol
  • JHS
  • BSE Symbol
  • 532771
  • Managing Director
  • Mr. Nikhil Nanda
  • ISIN
  • INE544H01014

Similar Stocks to JHS Svendgaard Laboratories

JHS Svendgaard Laboratories FAQs

JHS Svendgaard Laboratories share price is ₹21 As on 21 November, 2024 | 14:30

The Market Cap of JHS Svendgaard Laboratories is ₹184 Cr As on 21 November, 2024 | 14:30

The P/E ratio of JHS Svendgaard Laboratories is -15.7 As on 21 November, 2024 | 14:30

The PB ratio of JHS Svendgaard Laboratories is 1.1 As on 21 November, 2024 | 14:30

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23